MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is often treated with doxorubicin. MicroRNAs have been shown to have important regulatory roles in cancer and serve as a target in chemoresistance. In this study, we investigated the effects of specific microRNA-200a (miR-200a) on HCC tumor cell growth and effect of do...

全面介紹

書目詳細資料
Main Authors: Xiao Cui, Dachen Zhou, Qiang Du, Peiqi Wan, Kun Dong, Hui Hou, David A. Geller
格式: Article
語言:English
出版: Elsevier 2020-10-01
叢編:Translational Oncology
在線閱讀:http://www.sciencedirect.com/science/article/pii/S1936523320303004

相似書籍